Variant report
Variant | nsv613446 |
---|---|
Chromosome Location | chr9:11709025-11820083 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTPRD-10 | chr9:11819221-11819360 | l_3733_chr9:11816028-11824988_testes |
2 | lnc-PTPRD-10 | chr9:11816029-11816601 | l_3733_chr9:11816028-11824988_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371312448 | chr9:11728621-11728622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576708454 | chr9:11728624-11728625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564305781 | chr9:11728628-11728629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533192297 | chr9:11728636-11728637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549888118 | chr9:11728654-11728655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372804498 | chr9:11728672-11728673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569731331 | chr9:11728677-11728678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180797137 | chr9:11728714-11728715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566463508 | chr9:11728723-11728724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536146967 | chr9:11728750-11728751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377250630 | chr9:11728754-11728755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7024387 | chr9:11728789-11728790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs185201675 | chr9:11728796-11728797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572618667 | chr9:11728809-11728810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12350169 | chr9:11728848-11728849 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs577792744 | chr9:11728852-11728853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs3926216 | chr9:11728856-11728857 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs190307062 | chr9:11728859-11728860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181108519 | chr9:11728911-11728912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79515654 | chr9:11728929-11728930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542723111 | chr9:11728930-11728931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186097548 | chr9:11728931-11728932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573205215 | chr9:11728936-11728937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191819700 | chr9:11728942-11728943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564259525 | chr9:11728947-11728948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533283179 | chr9:11728949-11728950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs12350218 | chr9:11728990-11728991 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs184045367 | chr9:11729004-11729005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188975976 | chr9:11729019-11729020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73405330 | chr9:11729025-11729026 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs115061802 | chr9:11729039-11729040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139050787 | chr9:11729048-11729049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145270258 | chr9:11729049-11729050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552034585 | chr9:11729083-11729084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10960131 | chr9:11729084-11729085 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs537352294 | chr9:11729091-11729092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370932061 | chr9:11729117-11729118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535839583 | chr9:11729119-11729120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557093234 | chr9:11729122-11729123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191877092 | chr9:11729135-11729136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114289945 | chr9:11729139-11729140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs118079540 | chr9:11729146-11729147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201893070 | chr9:11729156-11729157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545041434 | chr9:11729181-11729182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1486804 | chr9:11729182-11729183 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs182924607 | chr9:11729204-11729205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144990876 | chr9:11729231-11729232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368315134 | chr9:11729248-11729249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73405332 | chr9:11729275-11729276 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs186496053 | chr9:11729289-11729290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Schizophrenia | 18511947 | CNVD |
Schizophrenia | 23813976 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11728600-11729400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr9:11728800-11729200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr9:11729000-11729400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr9:11743000-11743800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:11748800-11750000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr9:11775800-11776400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
7 | chr9:11779600-11780800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr9:11788400-11788600 | Enhancers | Pancreas | Pancrea |
9 | chr9:11795000-11795400 | Bivalent Enhancer | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr9:11806000-11806600 | Enhancers | Fetal Heart | heart |
11 | chr9:11812600-11813000 | Enhancers | Fetal Brain Male | brain |
12 | chr9:11819200-11820000 | Weak transcription | Fetal Brain Male | brain |
13 | chr9:11820000-11820200 | Enhancers | Fetal Brain Male | brain |
14 | chr9:11820000-11821400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |